| Utestående aktier | 10,376,109 shares |
| Insideraktier | 1 167 438 shares |
| Insynsägande | 11,25 % |
| Totalt antal insynspersoner | 32 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
4935 out of 11237Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Brainstorm Cell Therapeutics Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| ACC International Holdings Ltd. - | 67 053 | 4 470 | |
| ACCBT Corp. | 3 181 925 | ||
| Irit Arbel Director - [D] | 41 054 | 41 054 | |
| Sankesh Abbhi Director - [D] | 11 323 | 755 | |
| June Sherie Almenoff Director - [D] | 6 000 | 400 | |
| Arturo Araya Chief Commercial Officer - [O] | 8 608 | 574 | |
| Menghisteab Bairu Director - [D] | 24 000 | 24 000 | |
| Yoram Bibring Chief Financial Officer - [O] | 50 000 | 3 333 | |
| Dagher Ibrahim B. Chief Medical Officer - [O] | 535 742 | 535 742 | |
| Jacob A Frenkel Director - [D] | 43 777 | 43 777 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Fiorino Anthony S. Chief Executive Officer - [O] | 2 500 | 167 | |
| Mordechai Friedman Director - [D] | 0 | 0 | |
| Hartoun Hartounian EVP, Chief Operating Officer - [O] | 52 000 | 52 000 | |
| Adrian Harel | 70 000 | ||
| Avi Israeli | 133 334 | ||
| Kern Ralph Dr. COO and Chief Medical Officer - [O] | 223 310 | 14 887 | |
| Chaim Lebovits President & CEO - [O] | 200 960 | 200 960 | |
| Stacy Lindborg Director - [D] | 48 229 | 48 229 | |
| Nir Naor Director - [D] | 31 465 | 31 465 | |
| Alla Patlis See Remarks - [O] | 44 349 | 44 349 | |
| Alon Pinkas | 15 333 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Polverino Anthony J. Director - [D] | 25 730 | 25 730 | |
| Eyal Rubin CFO and Treasurer - [O] | 25 000 | 1 667 | |
| Robert G L Shorr Director - [D] | 45 731 | 3 049 | |
| Chen Schor Director - [D] | 121 558 | 8 104 | |
| David Setboun EVP and COO - [O] | 55 000 | 3 667 | |
| Preetam Shah EVP, CFO and Treasurer - [O] | 11 600 | 773 | |
| Liat Sossover | 100 000 | ||
| Malcolm S Taub Director - [D] | 77 332 | 5 155 | |
| Kirk Taylor Chief Medical Officer - [O] | 35 000 | 2 333 | |
| Anthony Waclawski See Remarks - [O] | 35 000 | 2 333 | |
| Uri Yablonka EVP & Chief Business Officer, Director - [D] [O] | 68 464 | 68 464 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i BCLI / Brainstorm Cell Therapeutics Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i BCLI / Brainstorm Cell Therapeutics Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 2025-01-01 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 50 000 | 66 849 | ||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. | BCLI | Common Stock | D | 315 742 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160 000 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30 000 | ||||||||
| 2025-01-03 | 2025-01-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 120 000 | 200 960 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | FRENKEL JACOB A | BCLI | Common Stock | D | 40 000 | 43 777 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 24 000 | 25 730 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 20 000 | 68 464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 40 000 | 48 464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Naor Nir | BCLI | Common Stock | D | 30 666 | 31 465 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Patlis Alla | BCLI | Common Stock | D | 40 000 | 44 349 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 50 000 | 52 000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 20 000 | 48 229 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Bairu Menghisteab | BCLI | Common Stock | D | 24 000 | 24 000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 30 666 | 41 054 | ||||||
| 2024-10-02 | 2024-10-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 3,4272 | 1 836 | 6 | 80 960 | ||||
| 2024-10-02 | 2024-09-30 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,2280 | 22 000 | 5 | 1 186 865 | ||||
| 2024-07-31 | 2024-05-22 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,6400 | 25 000 | 16 | 1 149 865 | ||||
| 2024-07-31 | 2024-05-21 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5790 | 25 000 | 14 | 1 124 865 | ||||
| 2024-07-31 | 2024-05-28 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5183 | 15 000 | 8 | 1 164 865 | ||||
| 2024-07-31 | 2024-05-13 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4900 | 10 000 | 5 | 1 099 865 | ||||
| 2024-07-31 | 2024-05-11 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4665 | 10 000 | 5 | 1 089 865 | ||||
| 2024-07-31 | 2024-05-10 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4650 | 20 000 | 9 | 1 079 865 | ||||
| 2024-07-31 | 2024-05-06 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,3753 | 135 000 | 51 | 993 565 | ||||
| 2024-07-31 | 2024-05-07 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,3743 | 66 300 | 25 | 1 059 865 | ||||
| 2024-07-31 | 2024-04-19 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5199 | 15 000 | 8 | 858 565 | ||||
| 2024-07-31 | 2024-04-18 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5255 | 115 072 | 60 | 843 565 | ||||
| 2024-07-31 | 2024-04-17 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5457 | 130 000 | 71 | 728 493 | ||||
| 2024-07-24 | 2024-07-19 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 0,3503 | −63 000 | −22 | 0 | ||||
| 2024-06-25 | 2024-06-24 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 30 000 | 30 000 | ||||||
| 2024-06-03 | 2024-05-28 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5183 | 15 000 | 8 | 1 164 865 | ||||
| 2024-05-23 | 2024-05-22 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,6400 | 25 000 | 16 | 1 149 865 | ||||
| 2024-05-23 | 2024-05-21 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5790 | 25 000 | 14 | 1 124 865 | ||||
| 2024-05-14 | 2024-05-13 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4900 | 10 000 | 5 | 1 099 865 | ||||
| 2024-05-14 | 2024-05-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4665 | 10 000 | 5 | 1 089 865 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4650 | 20 000 | 9 | 1 079 865 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,3743 | 66 300 | 25 | 1 059 865 | ||||
| 2024-05-07 | 2024-05-06 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,3753 | 135 000 | 51 | 993 565 | ||||
| 2024-04-25 | 2024-04-19 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5199 | 15 000 | 8 | 858 565 | ||||
| 2024-04-22 | 3 | Dagher Ibrahim B. | BCLI | Common Stock | D | 63 000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30 000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160 000 | ||||||||
| 2024-04-19 | 2024-04-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5255 | 115 072 | 60 | 843 565 | ||||
| 2024-04-19 | 2024-04-17 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5457 | 130 000 | 71 | 728 493 | ||||
| 2024-03-13 | 2024-03-11 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 241 935 | 423 435 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Yablonka Uri | BCLI | Common Stock | D | 109 426 | 126 969 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Patlis Alla | BCLI | Common Stock | D | 65 246 | 65 246 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 305 198 | 598 493 | ||||||
| 2023-09-05 | 2023-09-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 1,7741 | 11 500 | 20 | 181 500 | ||||
| 2023-08-07 | 2023-08-02 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35 000 | 170 000 | ||||||
| 2023-08-04 | 2023-08-02 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 293 295 | ||||||
| 2023-06-21 | 2023-06-19 | 4 | Naor Nir | BCLI | Common Stock | D | 11 999 | 11 999 | ||||||
| 2023-05-01 | 2023-05-01 | 4 | Taylor Kirk | BCLI | Common Stock | D | 35 000 | 35 000 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 75 000 | 262 110 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 75 000 | 135 000 | ||||||
| 2023-01-04 | 2022-12-07 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35 000 | 60 000 | ||||||
| 2023-01-04 | 2022-09-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 187 110 | ||||||
| 2022-04-08 | 2022-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50 000 | 50 000 | |||||
| 2022-03-14 | 2022-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35 885 | 223 310 | ||||||
| 2022-02-03 | 2022-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3 882 | 25 960 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2 000 | 22 078 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12 000 | 77 332 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2 000 | 6 000 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2021-12-17 | 2021-12-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35 885 | 187 425 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12 000 | 65 332 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 155 925 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2 000 | 20 078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2 216 | 18 078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 6 666 | 11 323 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50 000 | 50 000 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2 000 | 4 000 | ||||||
| 2020-12-31 | 2020-12-30 | 4 | Shah Preetam | BCLI | Common Stock | D | 4,6400 | −25 000 | −116 | 11 600 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Lindborg Stacy | BCLI | Call Option (right to buy) | D | 10,00 | 11 000,0000 | 200 | 2 200 | 200 | |||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Stock Option (Right to Buy) | D | 12,58 | 80 000 | 80 000 | |||||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Common Stock | D | 35 000 | 35 000 | ||||||
| 2020-07-31 | 2020-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 124 740 | ||||||
| 2020-07-16 | 2020-07-15 | 4 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 12,9900 | 46 779 | 608 | 2 164 530 | ||||
| 2020-07-16 | 2020-07-16 | 4 | Setboun David | BCLI | Common Stock | D | 12,9480 | 5 000 | 65 | 55 000 | ||||
| 2020-07-16 | 2020-07-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,4668 | −7 823 | −105 | 67 053 | ||||
| 2020-07-16 | 2020-07-15 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,1153 | −18 430 | −242 | 74 876 | ||||
| 2020-07-16 | 2020-07-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,5238 | −40 000 | −541 | 93 306 | ||||
| 2020-07-16 | 2020-07-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,3500 | −2 000 | −27 | 133 306 | ||||
| 2020-07-16 | 2020-07-09 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,1253 | −3 500 | −46 | 135 306 | ||||
| 2020-06-26 | 2020-06-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 10 000 | 17 543 | ||||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Stock Option (right to buy) | D | 7,67 | 100 000 | 100 000 | |||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 25 000 | 25 000 | ||||||
| 2020-04-07 | 2020-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50 000 | 50 000 | |||||
| 2020-04-07 | 2020-04-07 | 4 | Setboun David | BCLI | Common Stock | D | 50 000 | 50 000 | ||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4 235 502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4 235 502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4 235 502 | ||||||||
| 2020-04-07 | 2020-04-06 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 4 657 | 4 657 | ||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113 334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113 334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113 334 | ||||||||
| 2020-03-13 | 2020-03-09 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 7,33 | 80 000 | 80 000 | |||||
| 2020-03-06 | 2020-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35 885 | 151 540 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12 000 | 53 332 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2 000 | 2 000 | ||||||
| 2020-02-14 | 2020-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3 071 | 15 862 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2 000 | 12 791 | ||||||
| 2019-12-27 | 2019-12-24 | 4 | Araya Arturo | BCLI | Common Stock | D | 3,9000 | 3 000 | 12 | 8 608 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Shah Preetam | BCLI | Common Stock | D | 3,9594 | 11 600 | 46 | 36 600 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3,8800 | 3 000 | 12 | 115 655 | ||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 3,96 | 100 000 | 100 000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 6,00 | 100 000 | 100 000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Common Stock | D | 25 000 | 25 000 | ||||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2,25 | −6 666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2,25 | −6 666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 3,6672 | −13 332 | −49 | 155 833 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2,2500 | 6 666 | 15 | 169 165 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2,2500 | 6 666 | 15 | 169 165 | ||||
| 2019-07-26 | 2019-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 2 166 155 | ||||||
| 2019-03-08 | 2019-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35 885 | 112 655 | ||||||
| 2019-02-22 | 2019-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3 501 | 10 791 | ||||||
| 2019-01-08 | 2019-01-04 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,3900 | 1 475 | 5 | 7 175 | ||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen By The C. Schor Irrevocable Trust | BCLI | Common Stock | I | 121 558 | 121 558 | ||||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen | BCLI | Common Stock | D | −121 558 | 4 000 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12 000 | 41 332 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 1 667 | 7 290 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2 000 | 5 623 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Schor Chen | BCLI | Common Stock | D | 2 000 | 125 558 | ||||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Stock Option (right to buy) | D | 3,98 | 200 000 | 200 000 | |||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Common Stock | D | −2 805 | 5 608 | ||||||
| 2018-07-27 | 2018-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 2 134 970 | ||||||
| 2018-03-26 | 2018-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35 885 | 76 770 | ||||||
| 2018-03-26 | 2018-03-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 1 249 | 8 413 | ||||||
| 2018-03-20 | 2018-03-15 | 4/A | Kern Ralph Dr. | BCLI | Common Stock | D | 3,5994 | 5 000 | 18 | 40 885 | ||||
| 2018-03-20 | 2018-03-15 | 4/A | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,5000 | 5 700 | 20 | 5 700 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3,5994 | 5 000 | 18 | 40 885 | ||||
| 2018-03-16 | 2018-03-15 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,5000 | 5 700 | 20 | 5 700 | ||||
| 2018-02-28 | 2018-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 4 152 | 7 164 | ||||||
| 2018-02-05 | 2018-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3 623 | 3 623 | ||||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Stock Option (right to buy) | D | 4,30 | 93 686 | 93 686 | |||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Common Stock | D | 25 000 | 25 000 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Schor Chen | BCLI | Common Stock | D | 2 000 | 123 558 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12 000 | 29 332 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8 666 | 45 731 | ||||||
| 2017-08-31 | 2017-08-31 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 4,2600 | 2 500 | 11 | 155 833 | ||||
| 2017-08-23 | 2017-08-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 3,9800 | 2 000 | 8 | 7 543 | ||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 4,81 | 41 580 | 41 580 | |||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31 185 | 2 103 785 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | Yablonka Uri | BCLI | Common Stock | D | 5 543 | 5 543 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 12 000 | 12 000 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 4,18 | 47 847 | 47 847 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35 885 | 35 885 | ||||||
| 2017-03-03 | 2017-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 3 012 | 3 012 | ||||||
| 2017-02-28 | 2017-02-26 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 6 667 | 6 667 | |||||
| 2016-06-23 | 2016-06-22 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8 666 | 37 065 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8 666 | 17 332 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,75 | 15 333 | 15 333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | 16 666 | 16 666 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2015-12-17 | 2015-12-16 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,7100 | −10 800 | −29 | 28 399 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | −5 000 | 11 666 | |||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 2,5700 | −5 000 | −13 | 0 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 0,7500 | 5 000 | 4 | 5 000 | ||||
| 2015-12-16 | 2015-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,5900 | −11 263 | −29 | 8 666 | ||||
| 2015-12-16 | 2015-12-14 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,6100 | −30 479 | −80 | 19 929 | ||||
| 2015-12-14 | 2015-12-11 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,6600 | −980 | −3 | 50 408 | ||||
| 2015-12-14 | 2015-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,7400 | −12 500 | −34 | 51 388 | ||||
| 2015-12-14 | 2015-12-11 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,5600 | −5 300 | −14 | 39 199 | ||||
| 2015-12-14 | 2015-12-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,7100 | −5 500 | −15 | 44 499 | ||||
| 2015-12-03 | 2015-12-01 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3,17 | 82 500 | 82 500 | |||||
| 2015-10-13 | 2015-09-28 | 4/A | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2,45 | 369 619 | 369 619 | |||||
| 2015-10-02 | 2015-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2,5800 | 2 000 | 5 | 138 806 | ||||
| 2015-10-01 | 2015-09-28 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2,45 | 369 619 | 369 619 | |||||
| 2015-10-01 | 2015-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2,3400 | 9 200 | 22 | 136 806 | ||||
| 2015-08-31 | 2015-08-27 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8 666 | 49 999 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13 333 | 13 333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8 666 | 50 554 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,75 | 15 333 | 15 333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | 16 666 | 16 666 | |||||
| 2015-08-31 | 2015-08-27 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25 333 | 25 333 | |||||
| 2015-08-21 | 2015-08-20 | 4 | Bibring Yoram | BCLI | Common Stock | D | 3,0400 | 8 500 | 26 | 50 000 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Bibring Yoram | BCLI | Common Stock | D | 2,9200 | 41 500 | 121 | 41 500 | ||||
| 2015-08-03 | 2015-07-30 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3,17 | 165 000 | 165 000 | |||||
| 2015-06-03 | 2015-06-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 6 667 | 6 667 | |||||
| 2015-05-05 | 2015-05-03 | 4 | Schor Chen | BCLI | Common Stock | D | 60 000 | 121 558 | ||||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,5990 | 300 | 1 | 2 500 | ||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,5900 | 200 | 1 | 2 200 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9999 | 300 | 1 | 127 606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9499 | 700 | 3 | 127 306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9500 | 300 | 1 | 126 606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0100 | 400 | 2 | 126 306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9799 | 400 | 2 | 125 906 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9799 | 1 300 | 5 | 125 506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0099 | 600 | 2 | 124 206 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0399 | 600 | 2 | 123 606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0500 | 300 | 1 | 123 006 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0799 | 200 | 1 | 122 706 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0899 | 2 500 | 10 | 122 506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2900 | 1 000 | 4 | 120 006 | ||||
| 2014-10-01 | 2014-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0799 | 3 600 | 15 | 119 006 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,3200 | 1 000 | 4 | 115 406 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2150 | 500 | 2 | 114 406 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1200 | 1 000 | 4 | 113 906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1700 | 500 | 2 | 112 906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1800 | 100 | 0 | 112 406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,3000 | 1 800 | 8 | 112 306 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2900 | 2 000 | 9 | 110 506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2800 | 400 | 2 | 108 506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2700 | 1 000 | 4 | 108 106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2300 | 1 200 | 5 | 107 106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2000 | 500 | 2 | 105 906 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1800 | 300 | 1 | 105 406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1400 | 500 | 2 | 105 106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1000 | 300 | 1 | 104 606 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0500 | 500 | 2 | 104 306 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9400 | 1 000 | 4 | 103 806 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9000 | 1 500 | 6 | 102 806 | ||||
| 2014-09-19 | 2014-09-18 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,8400 | 800 | 3 | 2 000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2835 | 3 000 | 1 | 18 000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2875 | 5 000 | 1 | 15 000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2850 | 7 500 | 2 | 10 000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2800 | 2 500 | 1 | 2 500 | ||||
| 2014-08-19 | 2014-08-15 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130 000 | 620 000 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,05 | 380 000 | 380 000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130 000 | 628 333 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,05 | 230 000 | 230 000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,05 | 250 000 | 250 000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,05 | 200 000 | 200 000 | |||||
| 2014-06-20 | 2014-06-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,2900 | 130 000 | 38 | 1 519 600 | ||||
| 2014-06-16 | 2014-06-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,3500 | 150 000 | 52 | 1 389 600 | ||||
| 2014-06-10 | 2014-06-09 | 4 | Fiorino Anthony S. | BCLI | Stock Option (right to buy) | D | 0,30 | 5 700 000 | 5 700 000 | |||||
| 2014-06-09 | 2014-06-06 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,18 | 500 000 | 500 000 | |||||
| 2014-05-02 | 2014-04-28 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,3000 | 939 600 | 282 | 1 239 600 | ||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 133 334 | 133 334 | ||||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166 666 | 166 666 | ||||||
| 2014-01-03 | 2013-12-31 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,18 | 100 000 | 100 000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130 000 | 490 000 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,15 | 180 000 | 180 000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130 000 | 498 333 | ||||||
| 2013-04-23 | 2013-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166 666 | 166 666 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,15 | 130 000 | 130 000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,15 | 150 000 | 150 000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,15 | 180 000 | 180 000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,15 | 130 000 | 130 000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,15 | 150 000 | 150 000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0,26 | 70 000 | 70 000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,26 | 60 000 | 60 000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130 000 | 360 000 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130 000 | 368 333 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,26 | 60 000 | 60 000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0,26 | 70 000 | 70 000 | |||||
| 2012-04-17 | 2012-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166 666 | 166 666 | ||||||
| 2009-04-03 | 3 | TAUB MALCOLM S | BCLI | Common Stock | D | 1 250 000 | ||||||||
| 2007-08-08 | 2007-08-02 | 4 | ACCBT Corp. | BCLI | Right to Acquire Warrant to Purchase Common Stock | D | 636 385,00 | 3 181 925 | 3 181 925 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
